Clinical Trial

Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss

Name: Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss — clinical trial record (NCT05824065)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GENERA

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to evaluate the efficacy and safety of OMA102 1 mg and OMA102 2 mg versus placebo in the treatment of female pattern hair loss.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2023-04-11.

Trial Details

NCT Number	NCT05824065
Lead Sponsor	EMS
Conditions	Female Pattern Baldness
Enrollment	504 participants
Start Date	2025-01
Primary Completion	2027-01 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2024-02-16